Novel Life Science Reagents
| Product Number | Product Name | CAS RN | Molecular Formula | Application |
| CLA1004 | Aflibercept | 862111-32-8 | C4318H6788N1164O1304S32 |
|
| CLA1006 | Adalimumab | 331731-18-1 | C6428H9912N1694O1987S46 | |
| CLA1021 | Atezolizumab | 1380723-44-3 | C6446H9902N1706O1998S42 |
|
| CLA1015 | Eculizumab | 219685-50-4 | ||
| CLA1008 | Bevacizumab | 216974-75-3 | C6638H10160N1720O2108S44 | |
| CLA1009 | Rituximab | 174722-31-7 | C6416H9874N1688O1987S44 |
|
| CL1258 | Org 27569 | 868273-06-7 | C24H28ClN3O | |
| CL2592 | GSK2193874 | 1336960-13-4 | C37H38BrF3N4O | |
| CL1895 | GSK-690693 | 937174-76-0 | C21H27N7O3 | |
| CL1287 | Cobimetinib (GDC-0973) | 934660-93-2 | C21H21F3IN3O2 |
|
| CL1002 | Resatorvid (TAK-242) | 243984-11-4 | C15H17ClFNO4S | |
| CL1003 | Y-27632 Dihydrochloride | 129830-38-2 | C14H21N3O.2HCl | |
| CL1040 | Temoporfin | 122341-38-2 | C₄₄H₃₂N₄O₄ | |
| CL1011 | ICG-001 | 780757-88-2 | C33H32N4O4 | |
| CLA1003 | Trastuzumab | 180288-69-1 | C6470H10012N1726O2013S42 | Antineoplastic Agent |
Products
- Category
- Active Pharmaceutical Ingredients
- Pharmaceutical Intermediates
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies & Fusion Protein
- Bioactive Small Molecules
- Stable Isotope Labelled Compounds
- Cytokines
- Dye Reagents
- Drug Impurities & Metabolites
- Natural Products
- Building Blocks & Specialty Chemicals
